Please use this identifier to cite or link to this item: https://doi.org/10.1136/jmedgenet-2012-101155
DC FieldValue
dc.titleA multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants
dc.contributor.authorSharma M.
dc.contributor.authorIoannidis J.P.A.
dc.contributor.authorAasly J.O.
dc.contributor.authorAnnesi G.
dc.contributor.authorBrice A.
dc.contributor.authorBertram L.
dc.contributor.authorBozi M.
dc.contributor.authorBarcikowska M.
dc.contributor.authorCrosiers D.
dc.contributor.authorClarke C.E.
dc.contributor.authorFacheris M.F.
dc.contributor.authorFarrer M.
dc.contributor.authorGarraux G.
dc.contributor.authorGispert S.
dc.contributor.authorAuburger G.
dc.contributor.authorVilariño-Güell C.
dc.contributor.authorHadjigeorgiou G.M.
dc.contributor.authorHicks A.A.
dc.contributor.authorHattori N.
dc.contributor.authorJeon B.S.
dc.contributor.authorJamrozik Z.
dc.contributor.authorKrygowska-Wajs A.
dc.contributor.authorLesage S.
dc.contributor.authorLill C.M.
dc.contributor.authorLin J.-J.
dc.contributor.authorLynch T.
dc.contributor.authorLichtner P.
dc.contributor.authorLang A.E.
dc.contributor.authorLibioulle C.
dc.contributor.authorMurata M.
dc.contributor.authorMok V.
dc.contributor.authorJasinska-Myga B.
dc.contributor.authorMellick G.D.
dc.contributor.authorMorrison K.E.
dc.contributor.authorMeitnger T.
dc.contributor.authorZimprich A.
dc.contributor.authorOpala G.
dc.contributor.authorPramstaller P.P.
dc.contributor.authorPichler I.
dc.contributor.authorPark S.S.
dc.contributor.authorQuattrone A.
dc.contributor.authorRogaeva E.
dc.contributor.authorRoss O.A.
dc.contributor.authorStefanis L.
dc.contributor.authorStockton J.D.
dc.contributor.authorSatake W.
dc.contributor.authorSilburn P.A.
dc.contributor.authorStrom T.M.
dc.contributor.authorTheuns J.
dc.contributor.authorTan E.K.
dc.contributor.authorToda T.
dc.contributor.authorTomiyama H.
dc.contributor.authorUitti R.J.
dc.contributor.authorVan Broeckhoven C.
dc.contributor.authorWirdefeldt K.
dc.contributor.authorWszolek Z.
dc.contributor.authorXiromerisiou G.
dc.contributor.authorYomono H.S.
dc.contributor.authorYueh K.-C.
dc.contributor.authorZhao Y.
dc.contributor.authorGasser T.
dc.contributor.authorMaraganore D.
dc.contributor.authorKrüger R.
dc.date.accessioned2018-12-21T07:03:56Z
dc.date.available2018-12-21T07:03:56Z
dc.date.issued2012
dc.identifier.citationSharma M., Ioannidis J.P.A., Aasly J.O., Annesi G., Brice A., Bertram L., Bozi M., Barcikowska M., Crosiers D., Clarke C.E., Facheris M.F., Farrer M., Garraux G., Gispert S., Auburger G., Vilariño-Güell C., Hadjigeorgiou G.M., Hicks A.A., Hattori N., Jeon B.S., Jamrozik Z., Krygowska-Wajs A., Lesage S., Lill C.M., Lin J.-J., Lynch T., Lichtner P., Lang A.E., Libioulle C., Murata M., Mok V., Jasinska-Myga B., Mellick G.D., Morrison K.E., Meitnger T., Zimprich A., Opala G., Pramstaller P.P., Pichler I., Park S.S., Quattrone A., Rogaeva E., Ross O.A., Stefanis L., Stockton J.D., Satake W., Silburn P.A., Strom T.M., Theuns J., Tan E.K., Toda T., Tomiyama H., Uitti R.J., Van Broeckhoven C., Wirdefeldt K., Wszolek Z., Xiromerisiou G., Yomono H.S., Yueh K.-C., Zhao Y., Gasser T., Maraganore D., Krüger R. (2012). A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. Journal of Medical Genetics 49 (11) : 721-726. ScholarBank@NUS Repository. https://doi.org/10.1136/jmedgenet-2012-101155
dc.identifier.issn222593
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/150112
dc.description.abstractBackground Two recent studies identified a mutation (p.Asp620Asn) in the vacuolar protein sorting 35 gene as a cause for an autosomal dominant form of Parkinson disease. Although additional missense variants were described, their pathogenic role yet remains inconclusive. Methods and results We performed the largest multicenter study to ascertain the frequency and pathogenicity of the reported vacuolar protein sorting 35 gene variants in more than 15,000 individuals worldwide. p.Asp620Asn was detected in 5 familial and 2 sporadic PD cases and not in healthy controls, p.Leu774Met in 6 cases and 1 control, p.Gly51Ser in 3 cases and 2 controls. Overall analyses did not reveal any significant increased risk for p.Leu774Met and p.Gly51Ser in our cohort. Conclusions Our study apart from identifying the p. Asp620Asn variant in familial cases also identified it in idiopathic Parkinson disease cases, and thus provides genetic evidence for a role of p.Asp620Asn in Parkinson disease in different populations worldwide.
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.1136/jmedgenet-2012-101155
dc.description.sourcetitleJournal of Medical Genetics
dc.description.volume49
dc.description.issue11
dc.description.page721-726
dc.published.statePublished
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
jmedgenet-2012-101155.pdf220.75 kBAdobe PDF

OPEN

PublishedView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.